dementia

Dear Readers, In this issue, we kindly invite you to read articles which have been chosen for you by our Scientific Panels ALS and frontotemporal dementia , Autonomic nervous system disorders, Higher cortical functions, Movement disorders, Neurocritical care, Neurogenetics, Neurorehabilitation  … Continue Reading

A worldwide call to action, spearheaded by Western University researcher Dr. Vladimir Hachinski, is calling for more attention to the link between reducing strokes and preventing dementia.
Approximately 747,000 Canadians live with dementia, including Alzheimer’s diseases, which represents 14.9 per… Continue Reading

eBbrain e-learning programme (http://www.ebrainjnc.com) is a gold standard in interactive online learning tool for professionals in neuroscience. The vast majority of important neurological topics are already covered by eBrain. The others are in the process of developing. The module on… Continue Reading

For November 2015, we have selected: Kalra L, Irshad J, Simpson J, et al., on behalf of the STROKE-INF Investigators. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled trial. Lancet Neurology 2015; September 4. Dysphagia is common after a stroke, and associated with an increased risk of pneumonia and mortality. However, the use of antibiotics to prevent post-stroke pneumonia has been controversial.

The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for… Continue Reading

The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for… Continue Reading

3rd international Conference on new therapies for Parkinson and Alzheimer diseases (IPAD 3)
Pisa, Italy
September 18-19, 2015 The 3rd International Conference on New Therapies for Dementia and Parkinsonian Syndromes will take place in Pisa on September 18 and 19,… Continue Reading

In this issue of the Neuropenews, our Subspecialty Scientific Panel Sleep-wake disorders invites you to read an article on Alzheimer’s disease: “Alzheimer’s disease (AD) is the most frequent dementia. Sporadic AD is thought to be due, in part, to impaired… Continue Reading

Following invitation by Alzheimer Europe, Professor Günther Deuschl, EAN President, and the EAN Board accepted to sign the Alzheimer Europe Glasgow Declaration. The “Glasgow Declaration” calls for the creation of a European Dementia Strategy and national strategies in every country… Continue Reading

For July 2015, we have selected: Kazui H, Miyajima M, Mori E, Ishikawa M, for the SINPHONI-2 Investigators. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomized trial. Lancet Neurology 2015;14:585-594. The decision to refer patients with idiopathic normal pressure hydrocephalus (NPH) for surgery can be challenging for the neurologist, especially due to the lack of high-level evidence supporting the beneficial use of CSF shunts.

In the June issue of the European Journal of Neurology, members of the Subspecialty Scientific Panel Dementia and Cognitive Disorders panel of the European Academy of Neurology publish a Guideline on concomitant use of cholinesterase inhibitors (ChEI) and memantine in moderate to severe Alzheimer’s disease (AD).

The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for… Continue Reading

Below is an article of special interest recommended in the last issue of the
EBC – external environment report First WHO Ministerial Conference on Global Action Against Dementia (WHO Europe) On 16 and 17 March 2015, WHO will be hosting… Continue Reading

Gian Luigi Lenzi (GLL): How do you see the role of patient and carers organisations in society, and, specifically, Alzheimer Europe? Jean Georges (JG): Most Alzheimer associations were initially set up for three principal reasons: to provide information on Alzheimer’s disease and other forms of dementia, to provide support to people with dementia and their carers and to raise the awareness of the general public. Since the early days of the Alzheimer movement, some associations have taken on additional tasks such as lobbying governments for a greater recognition of dementia as a public health priority or funding dementia research.

I would like to express my gratitude towards the European Academy of Neurology for the honour to organize the Regional Teaching Course in Sofia, Bulgaria which proved to be an event excelling in terms of attendance and content. In this respect I would like to thank all the invited speakers for their great responsiveness and support.